For guidance on the regulation of research compounds in the UK, see the MHRA
No, tirzepatide is not FDA-approved for erectile dysfunction and has no direct mechanism targeting sexual function
One critical area of focus in our practice is the management of diabetes and weight-related conditions through innovative therapies, including treatments that target the hormone GLP-1
Canine conditions or diseases in which diet composition may have an effect on disease progression or outcome include kidney disease, foodborne and environmental allergies, neurologic conditions, pancreatitis, bladder stones, dysbiosis/chronic inflammatory intestinal disease, metabolic diseases (eg, diabetes mellitus), liver disease, joint disease, and dental disease